Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$4.1B
161M shares
52-week range
$18.77 – $30.42
56% from low
Sector
DENTAL EQUIPMENT & SUPPLIES
Exchange
NYSE
CS
P/S (TTM)
1.5
EV / FCF (TTM)
17.9
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
www.envistaco.comNo one on the platform currently holds NVST.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,208,165 | $30.7M |
| Bridgewater Associatesas of 2026-03-31 | 76,437 | $1.9M |
| Execution date | Ratio |
|---|---|
| 2008-08-19 | 1-for-10reverse |
| 2006-01-12 | 1-for-300reverse |
No one on the platform has traded NVST yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 1.7% | — | — | — | ||
| Rev. Growth % | 8.3% | 7.1% | ||||
| Profit Margin % | 1.7% | -4.7% | 1.6% | |||
| Free Cash Flow Margin % | 8.5% | 9.1% | 10.7% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is +1.0% on the P/E track.
At today's price, your expected annual return is +6.2% on the P/E track.
At today's price, your expected annual return is +10.5% on the P/E track.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $2.9B | +9.0% | $1.53 | $1.51–$1.54 | 16.5× | 10 |
| 2027 | $3.0B | +3.5% | $1.67 | $1.61–$1.72 | 15.2× | 10 |
| 2028 | $3.1B | +3.7% | $1.82 | $1.32–$2.36 | 13.9× | 7 |
| 2029 | $3.2B | +2.6% | $1.98 | $1.95–$2.02 | 12.8× | 2 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 8 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-05 | $0.34 | $0.41 | +22.3% |
| 2026-05-06 | $0.31 | $0.36 | +16.1% |
| 2026-02-05 | $0.32 | $0.38 | +18.8% |
| 2025-10-29 | $0.27 | $0.32 | +18.5% |
| 2025-07-31 | $0.24 | $0.26 | +8.3% |
| 2025-05-01 | $0.20 | $0.24 | +20.0% |
| 2025-02-05 | $0.23 | $0.24 | +4.3% |
| 2024-10-30 | $0.09 |
| $0.12 |
| +33.3% |
| $3.4B |
| — |
| GRALGRAIL Inc. | $74.34 | -1.58% | $3.2B | — |
| ICUIICU Medical, Inc. | $155.37 | -1.42% | $3.9B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
New AI report: $NVST NVST shows strong operational momentum and growth potential in specialty dental products but faces elevated valuation and debt risks. Recent earnings… Forecast, price targets & a multi-horizon plan: https://app.k3vl4r.com/r/nvst-ai-stock-forecast-986f1316a1155bfdadbfde0f9a05e3c9?utm_source=x&utm_medium=social&utm_campaign=report_drop&utm_content=NVST #stocks #trading
View on StockTwits ↗
Wall St is expecting 0.36 EPS for $NVST Q3 [Reporting 11/04 AMC] http://www.estimize.com/intro/nvst?chart=historical&metric_name=eps&utm_co
View on StockTwits ↗
$NVST Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.33 up 106.25% YoY • Reported revenue of $730.5M up 7.10% YoY • Envista Holdings Corporation is raising its full year 2026 outlook, now projecting core sales growth of 3.5% to 4.5%, adjusted EBITDA growth of 11% to 14%, and adjusted diluted EPS of $1.50 to $1.55.
View on StockTwits ↗
$NVST pullback to 26 and holding is ideal.. run away price action is better.
View on StockTwits ↗
Digital dentistry is becoming a platform race. Align, Envista, and Dentsply Sirona are all competing to build connected ecosystems spanning imaging, AI, treatment planning, and clinical workflows — not just individual products. Align faces an Elliott-backed strategic review. Envista and Dentsply report earnings next week. https://prismmarketview.com/digital-dentistrys-next-phase-is-about-platforms-not-products/ $ALGN $XRAY $NVST #dentalcare #dentistry #algn #nvst #DigitalDentistry
View on StockTwits ↗
$ALP $NASA $BE $NVST $PLUG Back then, INVESTORS didn't want me, now I'm hot, INVESTORS all on me. Cant wait to blast my music when all my stocks goes 100-1000%. I listen to hiphop music but this was my favorite jam when I was 18 years old.... https://www.youtube.com/watch?v=m1ERvlxgCD8
View on StockTwits ↗
$NVST Share Price: $25.90 Contract Selected: Dec 18, 2026 $25 Calls Buy Zone: $3.06 – $3.78 Target Zone: $4.90 – $5.98 Potential Upside: 51% ROI Time to Expiration: 182 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗
10X POTENTIAL 🔥🚨 $NVST 30 CALL 7/17 avg .30🚨
View on StockTwits ↗
https://marketbeat.com/a/8651703/ $NVST Envista Q1 Earnings Call Highlights
View on StockTwits ↗
$NVST Biopharmaceutical companies are entering an aggressive acquisition and R&D investment cycle to expand therapeutic portfolios and accelerate pipeline development, accepting near-term earnings pressure for long-term growth. Learn more: https://axlfi.com/themes/220
View on StockTwits ↗
$DASH $EZPW $NVST $PTC $ORA AFTER-HOURS MOVERS: Currently Higher After Earnings: - Noodles & Company (NDLS) up 21.1% - Fortinet (FTNT) up 15.9% - Kulicke and Soffa Industries (KLIC) up 15.4% - Cognex (CGNX) up 14.0% - Array Technologies (ARRY) up 11.3% - DoorDash (DASH) up 10.8% - EZCORP (EZPW) up 9.9% - Envista Holdings (NVST) up 6.8% - PTC Inc. (PTC) up 7.6% - Ormat Technologies (ORA) up 6.6% - AppLovin (APP) up 0.4% Currently Lower After Earnings: - Fastly (FSLY) down 25.3% - Whirlpool (WHR) down 16.4% - Tutor Perini (TPC) down 9.7% - Core Scientific (CORZ) down 8.0% - Amprius Technologies (AMPX) down 8.4% - Snap (SNAP) down 9.5% - Coherent (COHR) down 7.2% - Arm (ARM) down 6.4% - IonQ (IONQ) down 6.2% - Zillow (ZG) down 5.8% .
View on StockTwits ↗$NVST Q1 '26 Earnings Results & Recap Reported GAAP EPS of $0.24 up 140.00% YoY
View on StockTwits ↗
Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.